QIM
VKTX icon

Quantitative Investment Management’s Viking Therapeutics VKTX Stock Holding History

Quantitative Investment Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
+41,416
New +$1.34M 0.18% 157
2026
Q1 		– Sell
-12,842
Closed -$451K – 563
2025
Q4 		$451K Buy
+12,842
New +$455K 0.04% 325
2025
Q1 		– Sell
-48,455
Closed -$1.95M – 490
2024
Q4 		$1.95M Buy
+48,455
New +$2.76M 0.15% 131
2024
Q3 		– Sell
-84,567
Closed -$4.48M – 449
2024
Q2 		$4.48M Buy
+84,567
New +$5.54M 0.49% 49

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quantitative Investment Management's VKTX Position: Q2 2026 in Review

Quantitative Investment Management opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 41,416 shares worth $1.61M. The stake represents 0.18% of the portfolio and ranks #157 among its holdings. This is a return to the name: Quantitative Investment Management previously reported a position in VKTX as recently as Q4 2025.

Quantitative Investment Management first reported a position in VKTX in Q2 2024 and has held it in 4 quarters since. The position peaked at $4.48M in Q2 2024. 434 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Quantitative Investment Management held 41,416 shares of Viking Therapeutics worth $1.61M as of Q2 2026.
  • Viking Therapeutics was a new Quantitative Investment Management position in Q2 2026.
  • Viking Therapeutics made up 0.18% of Quantitative Investment Management's portfolio in Q2 2026, its #157 holding.
  • Quantitative Investment Management first reported a position in Viking Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Quantitative Investment Management's Viking Therapeutics position peaked at $4.48M in Q2 2024.
  • 434 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.